BioSpace News Archive

West Cancer Center & Research Institute announced today, seasoned financial professional, Matt Johnson, is joining the leading regional cancer center as its new Chief Financial Officer (CFO), effective May 3, 2020

AdhereHealth today announced the immediate availability of its new COVID-19 Adherence Solution, an innovative program that combines comprehensive predictive analytics and tech-enabled consumer outreach with home-delivered pharmacy services to support the Coronavirus crisis response.

CollPlant, a regenerative and aesthetics medicine company, announced that it will be hosting a webinar on Tuesday, May 12, 2020 at 11 am EDT/6 pm IDT that will feature its Co-Founder and Chief Scientist, Professor Oded Shoseyov and Chief Executive Officer, Mr. Yehiel Tal.

Baxter International Inc. announced an increase in the company’s quarterly cash dividend to a rate of $0.245 per share of common stock.

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that it has initiated testing of its CB5064 analogs in preclinical models of ARDS, to assess their potential as therapeutics for coronavirus disease 2019 (COVID-19) associated ARDS. In preclinical studies to date, these peptides have demonstrated the ability to a

FX201 preclinical in vivo data in a rodent model of OA showed slowing of disease progression 12 weeks post-surgery, persistence of the vector genome in the joint for at least 92 days with absence of systemic distribution, and a favorable safety profile Productivity, purification yields, and product quality from FX201 manufacturing studies demonstrate capable manufacturing process to support FX201 clinical trials BURLINGTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, I

BIOLASE, Inc., the global leader in dental lasers, announced that as dental offices plan to reopen, recent guidance from the American Dental Association recommends reducing aerosol production as much as possible to help prevent transmission of COVID-19.

DarioHealth Corp. (Nasdaq: DRIO) (“DarioHealth” or the “Company”), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial results on Tuesday, May 12, 2020 , and host

The first commercial sqid-X system sale to be used to triage COVID-19 patients in New York state

i oTech International announced today that three of its products, based on patented, proprietary, non-staining formulations of molecular iodine, are being used in an IRB approved, controlled clinical trial that was just initiated at St. Joseph’s Hospital University Medical Center in Patterson, NJ. The products being evaluated are ioRi